On November 3, the 2020 National Science and Technology Awards Conference was officially held in the Great Hall of the People in Beijing. The project "Key Technology and Application of Minimally invasive abdominal surgery Robot and Instrument" of Beijing Pelt Medical won the second prize of national Technological Invention Award in 2020.
As a domestic stapler leader, what is the endoscopic surgical robot developed by Pelter?
Previously, Pelt medical won the second prize of the National Science Progress Award for its research and development in the field of minimally invasive cancer, and the company won the title of "Specialized new Small and medium-sized Enterprise" in Beijing in 2021. These awards are the affirmation of Pelt medical research and development capabilities. Starting from the agent of French surgical sutures, to the independent research and development, production and sales of staplers, endoscopic staplers and intelligent electric staplers, and then to the launch of endoscopic surgical robots, The business territory of Pelte in the field of minimally invasive surgical instruments has gradually become clear.
Since its establishment in 2002, Pelt Medical has been promoting the iterative upgrading of its products, creating a product portfolio dominated by surgical staplers and assisted by disposable hernia repair devices, puncture devices, tissue closure clips, ultrasound knives and other surgical instruments. The company's intelligent electric endoscopic stapler and ultrasonic cutting hemostatic knife have obtained CE certification, among which the intelligent electric endoscopic stapler was recognized as innovative medical device by The Food and Drug Administration in July 2021, and subsequently approved to be listed in October.
At the same time, The company has excellent business promotion ability, in 2020, the company's sales network covers more than 1200 hospitals in China, including a total of more than 400 triple-a hospitals, products are exported to Germany, France, Britain, Spain, Canada, Brazil and other more than 60 countries and regions.
"In 2020, The sales volume of Pelt medical stapler ranked first among Chinese stapler manufacturers, and the export sales volume ranked first for five consecutive years from 2016 to 2020."
In the stapler market, The influence of Pelt medical has been self-evident. Why did such a company choose to make endoscopic surgery robots, and what kind of surgical robots did they develop?
Acquisition of Wessant, impact on a unique Chinese endoscopic surgery robot market
Endoscopic surgery is a new minimally invasive surgery, generally only need to cut 3 to 5 openings in the human body, used for inserting surgical instruments, laparoscopy, etc., has the advantages of small trauma, quick postoperative recovery, etc. With the wide development of minimally invasive surgery, surgical precision is further improved, surgical robot system arises at the right moment.
Endoscopic surgery robot is a combination of endoscopic technology and robot technology, with high precision, flexibility, good repeatability, not easy to be affected by human physiological factors such as fatigue and emotion, greatly improve the efficiency and quality of minimally invasive surgery, and effectively reduce the physical consumption of the surgical team.
Aiming at the minimally invasive cavity mirror market, Point medical has a keen "smell".
It is understood that as early as 2011, the company was optimistic about the surgical robot track, and began to develop surgical robot technology. As a rising star in the surgical robot industry, Wessant Medical has introduced a number of influential experts in the field of robotics, who have accumulated skills in mechanical systems, imaging, control algorithms, communication, simulation, surgical instrument development and other technologies. After repeatedly confirming wessant's excellent research and development strength, ability to solve clinical pain points, achievement transformation ability and product implementation ability, Pelt Medical decided to invest and hold the enterprise, formally entered the field of endoscopic surgery robot.
"Wessant medical's leading robotics technology is combined with The commercial capabilities of Pelt Medical, including its production chain and global sales network, to achieve good resource integration. Pelt Medical will focus on thoracic surgery and general surgery, and strive to achieve the curve overtaking of domestic endoscopic surgery robot."
China's endoscopic surgery robot market is also opening its arms to Domestic enterprises such as Pelt.
Worldwide, the surgical robot market is still in its infancy with low penetration. Endoscopic surgical robots are the fastest growing and most commercially successful sector. In the field of domestic surgical robots, endoscopic surgical robots account for nearly 75% of the market share. From 2015 to 2020, the number of robot-assisted endoscopic surgeries in China increased from 11,400 to 47,400, with a compound annual growth rate of 32.9%.
China's population aging process is accelerating and medical resources are distributed unevenly. Third-class hospitals in China need surgical robots to improve efficiency, and primary hospitals need robots to improve medical quality and realize medical homogenization. The Endoscopic surgical robot market in China has huge growth potential, with a market size of us $318 million in 2020, and is expected to grow rapidly at a COMPOUND annual growth rate of 39.2% from 2020 to 2026.
In China's endoscopic surgery robot market, only Da Vinci surgical robot and a domestic brand were approved. Da Vinci surgical robot is the largest in the world, which can be widely used in abdominal surgery, urology, obstetrics and gynecology and other departments. Currently, it has developed the fourth generation. Due to high import prices, lack of market education and other reasons, by the end of 2020, China's Da Vinci surgical robot installed only 200 units, far from meeting market demand. The huge gap between supply and demand needs to be filled by domestic brands.
The new generation of endoscopic surgery robot adopts active master hand technology and focuses on customized surgical instruments
At present, the new generation of endoscopic surgical robot developed by The Pyte Medical Institute can be compared with the fourth generation of Da Vinci surgical robot. From the perspective of specialty customization, the product focuses on thoracic surgery and general surgery, aiming at the surgery of lung, mediastinum, gastrointestinal, hepatobiliary, pancreas and other organs with large operation volume.
Through long-term close contact with the front-line clinical practice in China, Pelt is well aware of the clinical needs. In terms of technology, Pelt's endoscopic surgical robot is a certain leader. The new generation of endoscopic surgery robot uses active master hand technology, no unnecessary movement during the operation, the doctor can adjust the mechanical arm during the operation. The surgical robot has the function of tremor filtering, which can filter the physiological tremor of hands and achieve precise operation. At the same time, the system can also realize 5G remote communication and control, which conforms to the development of telemedicine in China.
Moreover, combined with pilt medical's accumulation in stapler, ultrasonic knife and other fields, the surgical robot system is equipped with a variety of surgical instruments. From the perspective of research and development capability and production cost, many surgical robots are equipped with only several medical instruments, leading to the need for assistants to operate key parts, such as organ structure reconstruction, through additional incisions and various instruments, including staplers, during surgery.
Through the independent production of supporting consumables, Pilte effectively reduces product costs and surgical costs. Especially from the perspective of surgical quality, the lead surgeon can achieve full control of the operation and independently complete the operation of key parts, thus improving the overall surgical efficiency and quality.
In terms of commercialization capabilities, the new generation of surgical robots has natural "soil". After nearly 20 years of development, Pert Medical has accumulated certain product registration, marketing and channel resources, before the company has distributed 1200 hospitals in China, with more than 400 dealers. On the international level, Pelt medical also has accumulated overseas subsidiaries, sales teams and dealers.
Under the guidance of adhering to the concept of focus and innovation, with the help of strong commercialization ability and technological advantages of robot products, we have the opportunity to see The Pelte Medical in the endoscope hand robot track faster and farther, truly provide "one-stop" service for minimally invasive surgery.
About Manly Battery
Located in Shenzhen,China. A leading battery manufacturer mainly offering rechargeable Lithium batteries over 12 years ,widly used for Robostic ,if there is any project need to evluate ,pls feel free to send email to info@manlybatteries.com
